Downregulation of hippocampal TN-R was observed in a small set of individuals with AD, compared to age-matched controls by Manavlan et al. (2013) [44] but this is to our knowledge the first study investigating TN-R as a potential biomarker for FTD. This evidence concerns the gene TNR and Alzheimer disease.